United States - English - NLM (National Library of Medicine)

dongguan tianzi baby baby supplies co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - / open the lid and the sticker, pull out the wipes needed and then press the sticker back and close the lid to avoid alcohol evaporation. do not use on sensitive position, like face eye, nose and mouth /

United States - English - NLM (National Library of Medicine)

dongguan tianzi baby infant and child products co.,ltd - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic

United States - English - NLM (National Library of Medicine)

sunshine lake pharma co., ltd. - esomeprazole magnesium (unii: r6dxu4way9) (esomeprazole - unii:n3pa6559ft) - healing of erosive esophagitis esomeprazole magnesium delayed-release capsule is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. for those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of esomeprazole magnesium delayed-release capsule may be considered. maintenance of healing of erosive esophagitis esomeprazole magnesium delayed-release capsule is indicated to maintain symptom resolution and healing of erosive esophagitis. controlled studies do not extend beyond 6 months. symptomatic gastroesophageal reflux disease esomeprazole magnesium delayed-release capsule is indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with gerd in adults and children 1 year or older. esomeprazole magnesium delayed-release capsule is indicated for the reduction in the occurrence of gastric ulcers associated with continuous nsaid therapy in patien

United States - English - NLM (National Library of Medicine)

sunshine lake pharma co., ltd. - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - oral olanzapine is indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13-17), efficacy was established in one 6-week trial [see clinical studies ( 14.1)] . when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions ( 5.5] . monotherapy — oral olanzapine is indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disord

United States - English - NLM (National Library of Medicine)

sunshine lake pharma co., ltd. - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - oral olanzapine is indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13 years to 17 years), efficacy was established in one 6-week trial [see clinical studies ( 14.1)] . when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions ( 5.5)] . monotherapy — oral olanzapine is indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of

United States - English - NLM (National Library of Medicine)

sunshine lake pharma co., ltd. - febuxostat (unii: 101v0r1n2e) (febuxostat - unii:101v0r1n2e) - febuxostat tablet is a xanthine oxidase (xo) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. for the safe and effective use of allopurinol, see allopurinol prescribing information. limitations of use : febuxostat tablets are not recommended for the treatment of asymptomatic hyperuricemia.febuxostat tablets are not recommended for the treatment of asymptomatic hyperuricemia. febuxostat tablets are contraindicated in patients being treated with azathioprine or mercaptopurine [see drug interactions (7)] . risk summary limited available data with febuxostat tablets use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. no adverse developmental effects were observed in embryo-fetal development studies with oral a

United States - English - NLM (National Library of Medicine)

sunshine lake pharma co., ltd. - duloxetine hydrochloride (unii: 9044sc542w) (duloxetine - unii:o5tnm5n07u) - duloxetine delayed-release capsules are indicated for the treatment of:duloxetine delayed-release capsules are indicated for the treatment of: - major depressive disorder in adults - generalized anxiety disorder in adults and pediatric patients 7 years of age and older - diabetic peripheral neuropathic pain in adults - fibromyalgia in adults - chronic musculoskeletal pain in adults additional pediatric use information is approved for eli lilly and company, inc.’s cymbalta (duloxetine) delayed-release capsules. however, due to eli lilly and company inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information. the use of maois intended to treat psychiatric disorders with duloxetine delayed-release capsules or within 5 days of stopping treatment with duloxetine delayed-release capsules is contraindicated because of an increased risk of serotonin syndrome. the use of duloxetine delayed-release capsules within 14 days of stopping an maoi intended to treat psychiatric disor

United States - English - NLM (National Library of Medicine)

dongguan zhongcheng sanitary commodities co., ltd. - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - antiseptic,wipes open the cap and pull off protective seal. gently pull out wipes. close cap after each use to maintain freshness. 1.peel the sticker open. 2.remove wet wipes. 3.reseal the sticker. - if irritation occurs, stop usage and consult a doctor. do not use if you are allergic to any of the ingredients. do not flush wipes down the toilet. - suitable for hands only. for external use only. not for use on baby's bottom. avoid using on eyes or wounded skin. store in a cool and dry place. keep out of reach of children. avoid direct sun exposure. if irritation occurs, stop usage and consult a doctor. do not use if you are allergic to any of the ingredients. do not flush wipes down the toilet.

United States - English - NLM (National Library of Medicine)

dongguan zhongcheng sanitary commodities co., ltd. - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - antiseptic,wipes open the cap and pull off protective seal. gently pull out wipes. close cap after each use to maintain freshness. 1.peel the sticker open. 2.remove wet wipes. 3.reseal the sticker. - if irritation occurs, stop usage and consult a doctor. do not use if you are allergic to any of the ingredients. do not flush wipes down the toilet. - suitable for hands only. for external use only. not for use on baby's bottom. avoid using on eyes or wounded skin. store in a cool and dry place. keep out of reach of children. avoid direct sun exposure. if irritation occurs, stop usage and consult a doctor. do not use if you are allergic to any of the ingredients. do not flush wipes down the toilet.

United States - English - NLM (National Library of Medicine)

dongguan zhongcheng sanitary commodities co., ltd. - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - antiseptic,wipes open the cap and pull off protective seal. gently pull out wipes. close cap after each use to maintain freshness. 1.peel the sticker open. 2.remove wet wipes. 3.reseal the sticker. - if irritation occurs, stop usage and consult a doctor. do not use if you are allergic to any of the ingredients. do not flush wipes down the toilet. - suitable for hands only. for external use only. not for use on baby's bottom. avoid using on eyes or wounded skin. store in a cool and dry place. keep out of reach of children. avoid direct sun exposure. if irritation occurs, stop usage and consult a doctor. do not use if you are allergic to any of the ingredients. do not flush wipes down the toilet.